title: Interferon: benefit beyond hepatitis therapy?
authors.affiliation: Division of Gastroenterology, Baylor College of Medicine, Houston, Texas, USA.
authors.forename: D B
authors.initials: DB
authors.lastname: Mallat
authors.forename: H B
authors.initials: HB
authors.lastname: El-Serag
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000517:prevention & control / Q000601:surgery* / Q000821:virology*; D006526:Hepatitis C / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000517:prevention & control / Q000601:surgery* / Q000821:virology*; D008137:Longitudinal Studies; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D011182:Postoperative Care; D016032:Randomized Controlled Trials as Topic
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha